
    
      This is a double-blind, randomized, parallel group, dose-response study to assess the safety
      and efficacy of three dose levels of CNS 7056 compared with midazolam to maintain suitable
      sedation levels in patients undergoing colonoscopy.

      Safety assessment will include physical examinations, vital signs, ECGs, pulse oximetry
      measurements, capnography, clinical chemistry and hematology laboratory tests, routine drug
      and ethanol screening, urinalysis, pregnancy test, pain on injection using a verbal scale,
      and monitoring of adverse events.
    
  